Biological and Immunological Characterization of a Human Liver Immunoregulatory Protein
Open Access
- 1 January 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 3 (6) , 939-946
- https://doi.org/10.1002/hep.1840030610
Abstract
The liver immunoregulatory protein (LIP) was originally characterized as human liver-derived soluble factor which inhibited the alloantigen and phytohemagglutinin-induced proliferation of human lymphocytes (1). Soluble extracts prepared under the same experimental conditions from kidney, spleen, heart, lymph nodes, and erythrocytes did not exert any inhibitory activity (2). The purpose of this study was to characterize the immunobiological properties of LIP. In the primary one-way mixed lymphocyte culture, LIP depressed the generation of suppressor T cells which inhibited the lymphocyte proliferation induced by phytohemagglutinin or alloantigens. In addition, LIP suppressed in primary mixed lymphocyte culture the induction of cytotoxic T cells and memory cells as determined by cell-mediated lympholysis and secondary mixed lymphocyte culture, respectively. In the presence of LIP, the concanavalin A-mediated induction of suppressor T cells, the pokeweed mitogen-induced IgG synthesis in vitro and the cytolytic activity of K cells reacting in the antibody-dependent cell-mediated cytotoxicity were also inhibited. Cytotoxic effects could be excluded since the viability of human lymphoblastoid cells, hepatocytes, and allogeneically stimulated lymphocytes was not affected by LIP. LIP was shown to be different from other liver-derived substances like acute phase proteins, immunoregulatory a-globulins, C-reactive protein, lipoproteins, and F antigen. Furthermore, LIP is not identical to other serum components like the immunoregulatory rosette inhibition factor and the serum inhibitory factor (3). However, the characteristics described herein strongly indicate that LIP is very similar to the liver extract described by Chisari (4) and the liver-derived inhibitory protein (LIP) described by Grol and Schumacher (5). With respect to the function in vivo, LIP could be an inherent part of the liver-located immune system, and one could postulate that LIP might be involved in the regulatory mechanisms which permit the emergence of autoaggressive responses and increased injury of hepatocytes.This publication has 20 references indexed in Scilit:
- The Comparison between Normal and Epstein-Barr Virus-Transformed Homozygous Typing Cells and Their Use for MLC, PLT and Serological Detection of Human Ia-Type AlloantigensTissue Antigens, 2008
- Immunoregulatory serum factors in acute and chronic hepatitisLiver International, 1982
- Theimunopathogenesis of cronic HBV inducedliver diseaseSpringer Seminars in Immunopathology, 1981
- Perifused monolayer cultures of rat hepatocytes as an improved in vitro system for studies on ureogenesisExperimental Cell Research, 1979
- DEMONSTRATION OF A DOG LIVER IMMUNOSUPPRESSIVE FACTOR ACTIVE IN VITROTransplantation, 1979
- ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY TESTS FOR IMMUNOSUPPRESSION MONITORING OF TRANSPLANT PATIENTSTransplantation, 1979
- SUPPRESSION OF GRAFT-VERSUS-HOST DISEASE BY MURINE CELL-FREE LIVER EXTRACTTransplantation, 1978
- Isolation and characterization of a liver-specific antigen (F-Ag) from human liverImmunochemistry, 1977
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- MOUSE TRANSPLANTATION ANTIGENSTransplantation, 1968